Smith & Nephew (SNN) Cash & Equivalents Growth (1y) (2010 - 2025)
Smith & Nephew (SNN) Cash & Equivalents Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -22.13% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 23.57% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -7.71% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | -10.02% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 141.82% |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | 156.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.02% |
| Jun 28, 2025 | 19.01% |
| Dec 31, 2024 | 104.97% |
| Dec 31, 2023 | -13.71% |
| Dec 31, 2022 | -72.87% |
| Dec 31, 2021 | -26.79% |
| Dec 31, 2020 | 585.60% |
| Jun 30, 2020 | 153.28% |
| Dec 31, 2019 | -22.82% |
| Jun 29, 2019 | 38.38% |
| Dec 31, 2018 | 114.84% |
| Dec 31, 2017 | 307.89% |
| Dec 31, 2016 | -62.75% |
| Dec 31, 2015 | 56.92% |
| Jun 30, 2015 | -37.14% |
| Dec 31, 2014 | -52.55% |
| Sep 30, 2014 | 8.09% |
| Jun 28, 2014 | 38.61% |
| Mar 31, 2014 | 45.60% |
| Dec 31, 2013 | -23.03% |